Breast Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Breast
| Protocol | AFT-25 COMET |
|---|---|
| Cancer Type: | Low Risk DCIS |
| Fast Facts |
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for Low Risk DCIS: A Phase III Prospective Randomized Trial
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | EA1181 |
|---|---|
| Cancer Type: | Neoadjuvant Breast |
| Fast Facts |
Preoperative THP and postoperative HP in patients who achieve a pathologic complete response
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | SWOG S1706 |
|---|---|
| Cancer Type: | Inflammatory Breast Cancer |
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy versus Radiotherapy Alone for Inflammatory Breast Cancer
| Protocol | Alliance A011801 |
|---|---|
| Cancer Type: | HER2 positive Breast Cancer |
The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | CCTG MA.39 Adjuvant |
|---|---|
| Cancer Type: | LOW RISK NODE POSITIVE BREAST CANCER |
| Fast Facts |
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
| Protocol | NRG BR007 |
|---|---|
| Cancer Type: | Stage 1, Hormone Sensitive Her2 negative |
| Fast Facts |
Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage 1, Hormone Sensitive HER2-Negative, Oncotype Recurrence Score < 18 Breast Cancer (DEBRA) De-Escalation of Breast Radiation
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | SWOG S2007 |
|---|---|
| Cancer Type: | HER2-Negative Breast Cancer |
| Fast Facts |
A Phase II Trial of Sacituzumab Govitecan for Patients with HER2-Negative Breast Cancer and Brain Metastases
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | PDM 9846 |
|---|---|
| Cancer Type: | Tissue Procurement |
| Fast Facts |
Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | SWOG S1501 CC cardiac tox |
|---|---|
| Cancer Type: | METASTATIC HER-2+ BREAST CANCER |
| Fast Facts |
Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients With Metastatic HER-2+ Breast Cancer, Phase III
| Protocol | SWOG S1703 |
|---|---|
| Cancer Type: | METASTATIC BREAST CANCER |
| Fast Facts |
Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored With Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients With Metastatic Hormone Receptor Positive HER-2 Negative Breast Cancer
| Protocol | URCC 16070 CC nausea |
|---|---|
| Cancer Type: | Cancer Control |
| Fast Facts |
Treatment of Refractory Nausea
| Protocol | URCC 18007 |
|---|---|
| Cancer Type: | Cancer-Related Fatigue |
| Fast Facts |
Randomized Placebo-Controlled Trial of Bupropion for Cancer-Related Fatigue
| Protocol | URCC 19085 |
|---|---|
| Cancer Type: | Cancer Control |
| Fast Facts |
Wireless Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy-Induced Peripheral Neuropathy: A Phase II Clinical Trial
| Protocol | Alliance A231901CD |
|---|---|
| Cancer Type: | CCDR |
| Fast Facts |
IMPROVING PATIENT-CENTERED COMMUNICATION IN BREAST CANCER: A RCT OF A SHARED DECISION ENGAGEMENT SYSTEM (SHARES)
| Protocol | Alliance A191901 |
|---|---|
| Cancer Type: | Cancer Control |
| Fast Facts |
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | EA1151 (TMIST) |
|---|---|
| Cancer Type: | Screening |
| Fast Facts |
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
